Upgrade to SI Premium - Free Trial

Genmab A/S (GMAB) PT Raised to $40 at H.C. Wainwright

July 2, 2026 6:41 AM
(Updated - July 2, 2026 6:41 AM EDT)

H.C. Wainwright analyst Raghuram Selvaraju raised the price target on Genmab ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change